Inventor · disambiguated record
Lena Tagmose
Also filed as: TAGMOSE LENA
13 granted patents·4 pending applications·42 citations·filing 2015–2024
90Inventor score
Top patents by PatentIndex Score
17 records- 0195US11111290B2Antibodies specific for hyperphosphorylated tau and methods of use thereofH LUNDBECK AS·Filed 2019·Granted Sep 7, 2021·6 cites·9 claims
- 0294US9346797B12-amino 6-(difluoromethyl)-5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitorsLUNDBECK & CO AS H·Filed 2015·Granted May 24, 2016·7 cites·19 claims
- 0392US10647762B2Antibodies specific for hyperphosphorylated tau and methods of use thereofH LUNDBECK AS·Filed 2019·Granted May 12, 2020·5 cites·3 claims
- 0490US9353084B22-amino 3,5,5-trifluoro-3,4,5,6-tetrahydropyridines as BACE1 inhibitors for treatment of Alzheimer's diseaseLUNDBECK & CO AS H·Filed 2015·Granted May 31, 2016·9 cites·22 claims
- 0589US10487142B2Antibodies specific for hyperphosphorylated tau and methods of use thereofH LUNDBECK AS·Filed 2019·Granted Nov 26, 2019·5 cites·3 claims
- 0688US10472415B2Antibodies specific for hyperphosphorylated tau and methods of useH LUNDBECK AS·Filed 2017·Granted Nov 12, 2019·5 cites·3 claims
- 0788US2025257124A1Antibodies specific for hyperphosphorylated tau and methods of use thereofH LUNDBECK AS·Filed 2024·Application pending·0 cites
- 0878US12129289B2Antibodies specific for hyperphosphorylated tau and methods of use thereofH LUNDBECK AS·Filed 2021·Granted Oct 29, 2024·0 cites·15 claims
- 0978US10045974B22-amino-6-(difluoromethyl)-5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitorsH LUNDBECK AS·Filed 2015·Granted Aug 14, 2018·1 cites·3 claims
- 1072US10603310B22-amino-6-(difluoromethyl)-5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitorsH LUNDBECK AS·Filed 2018·Granted Mar 31, 2020·0 cites·3 claims
- 1171US10011596B22-amino-3-fluoro-3-(fluoromethyl)-6-methyl-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitorsH LUNDBECK AS·Filed 2016·Granted Jul 3, 2018·1 cites·31 claims
- 1270US10004738B2Combination treatment comprising administration of 2-amino-3,5,5-trifluoro-3,4,5,6-tetrahydropyridinesH LUNDBECK AS·Filed 2016·Granted Jun 26, 2018·1 cites·22 claims
- 1369US10059669B22-amino-3,5-difluoro-3,6-dimethyl-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitors for treating alzheimer's diseaseH LUNDBECK AS·Filed 2015·Granted Aug 28, 2018·1 cites·18 claims
- 1469US10058540B22-amino-5,5-difluoro-6-(fluoromethyl)-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitorsH LUNDBECK AS·Filed 2015·Granted Aug 28, 2018·1 cites·15 claims
- 1542US2018186769A16-amino-5-fluoro-5-(fluoromethyl)-2,3,4,5-tetrahydropyridin-2-yl-phenyl-5-(methoxy-d3)-pyrazine-2-carboxamides and fluorinated derivatives thereof as bace1 inhibitorsH LUNDBECK AS·Filed 2017·Application pending·0 cites
- 1641US2017066741A12-Amino-3,5,5-Trifluoro-3,4,5,6-Tetrahydropyridines as BACE1 Inhibitors for Treatment of Alzheimer's DiseaseH LUNDBECK AS·Filed 2015·Application pending·0 cites
- 1738US2018230160A12-amino-7a-phenyl-3,4,4a,5,7,7a-hexahydrofuro[3,4-b]pyridines as bace1 inhibitorsH LUNDBECK AS·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lena Tagmose files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →